Shares of Evoke plc (LON:EVOK – Get Free Report) dropped 10% during mid-day trading on Thursday . The stock traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). Approximately 65,066,164 shares were traded during mid-day trading, an increase of 1,994% from the average daily volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Analyst Upgrades and Downgrades
A number of research firms have commented on EVOK. Jefferies Financial Group restated a “buy” rating and set a GBX 140 ($1.81) price objective on shares of Evoke in a research note on Monday, December 16th. Berenberg Bank decreased their price target on Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating on the stock in a research report on Wednesday, December 4th.
Get Our Latest Stock Report on Evoke
Evoke Price Performance
Evoke (LON:EVOK – Get Free Report) last posted its quarterly earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) EPS for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. As a group, research analysts predict that Evoke plc will post 12.7648305 earnings per share for the current year.
Insider Activity
In related news, insider Andrea Gisle Joosen acquired 14,572 shares of the company’s stock in a transaction that occurred on Tuesday, January 28th. The stock was acquired at an average price of GBX 70 ($0.91) per share, with a total value of £10,200.40 ($13,202.69). 27.00% of the stock is currently owned by corporate insiders.
About Evoke
Featured Articles
- Five stocks we like better than Evoke
- About the Markup Calculator
- MarketBeat Week in Review – 03/24 – 03/28
- Quiet Period Expirations Explained
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- What Makes a Stock a Good Dividend Stock?
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.